Status:
TERMINATED
Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor
Lead Sponsor:
Angela Bianco
Collaborating Sponsors:
Stryker Nordic
Conditions:
Cesarean Section
Surgical Site Infection
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Surgical site infections (SSI) are the second most common cause of nosocomial infections accounting for 15% of all nosocomial infections among hospitalized patients and 38% of nosocomial infections in...
Detailed Description
The study will be offered to women who are admitted to undergo labor at Mount Sinai Medical Center. The eligible women will be randomized to use of a 2% chlorhexidine gluconate (CHG) cloth with 4% chl...
Eligibility Criteria
Inclusion
- Women at \> 24 weeks gestation who are admitted in labor or admitted for induction of labor at Mount Sinai Hospital
Exclusion
- Allergy to chlorhexidine
- Unplanned or emergency cesarean section
- Women at \<24 weeks gestation
- Estimated fetal weight \<500 grams
- Fetal face presentation regardless of gestational age.
Key Trial Info
Start Date :
October 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 11 2021
Estimated Enrollment :
319 Patients enrolled
Trial Details
Trial ID
NCT03423147
Start Date
October 5 2018
End Date
February 11 2021
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029